Smith & Nephew Snats ADR(SNN-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low29.58
Day High30.04
Open:30.02
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
Tipranks
Citi Remains a Buy on Smith & Nephew (SN)
Tipranks
Smith & Nephew Plans Block Admission of Shares for Employee Incentive Schemes
Tipranks
Smith & Nephew Updates Voting Share Capital as of June 30, 2026
Tipranks
Cevian Capital Slightly Lifts Stake in Smith & Nephew
Tipranks
RBC Capital Sticks to Their Hold Rating for Smith & Nephew (SN)
Tipranks
Smith & Nephew Discloses Increased Cevian Stake Above 13%
Tipranks
Smith & Nephew (SN) Gets a Hold from Barclays
Tipranks
Barclays Remains a Hold on Smith & Nephew (SN)
Tipranks
Cevian Capital Lifts Smith & Nephew Stake to 12.24% Without Triggering New Threshold
Tipranks
Cevian Capital Lifts Smith & Nephew Stake Above 12% in June 2026
Tipranks
Analysts Offer Insights on Healthcare Companies: Ultragenyx Pharmaceutical (RARE), Align Tech (ALGN) and Smith & Nephew Snats (SNN)
GlobeNewswire
A Fresh FDA Catalyst Is Putting Regenerative Wound Care in Focus
GlobeNewswire
Smith+Nephew announces first clinical cases with the next generation CORIâ—ŠXT Handheld Robotics Platform across knee and shoulder arthroplasty
Tipranks
Smith & Nephew Executives Reinvest 2025 Final Dividend Into ADS Purchases
Tipranks
Smith & Nephew Executives Reinvest 2025 Final Dividend into Company Shares
Tipranks
Smith & Nephew Lists €500m Long-Dated Notes on London Stock Exchange
Tipranks
Goldman Sachs Sticks to Their Buy Rating for Smith & Nephew (SN)
Tipranks
Smith & Nephew Updates Share Capital and Voting Rights as of 31 May 2026
Tipranks
Smith & Nephew Admits Additional Shares From Employee Schemes to London Market

Profile

Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.